Floatz logo

ONDANSETRON

Acute Cholecystitis

Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research HospitalSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Acute Cholecystitis cohort.

Asset / SponsorPhaseRating
Allocetra-Ots
Enlivex Therapeutics Ltd.
Phase 2CCC
Indocyanine Green
Ohio State University
Phase 1CC
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
N/AD
(±)-TRAMADOL
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
N/AD

Same molecule, other indications

ONDANSETRON is also rated in:

cancer of unknown primary siteDormant
BB
Indicative · Phase 3
71 / 100
View asset →
childhood neoplasmDormant
BB
Indicative · Phase 3
66 / 100
View asset →
alcohol abuseDormant
BB
Indicative · Phase 4
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →